2019
DOI: 10.1155/2019/7658052
|View full text |Cite
|
Sign up to set email alerts
|

Chitosan Oligosaccharides Show Protective Effects in Coronary Heart Disease by Improving Antioxidant Capacity via the Increase in Intestinal Probiotics

Abstract: We explored the effects of chitosan oligosaccharides (COS) on coronary heart disease (CHD) patients. The component of COS was measured by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). CHD patients were evenly assigned into the COS group (COG) and the placebo group (CG). The duration of treatment was 6 months and therapeutic results were explored by measuring left ventricular ejection fraction (LVEF) value, Lee scores, quality of life (QOL), blood urea nitrogen, an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
21
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 37 publications
(25 citation statements)
references
References 50 publications
2
21
0
Order By: Relevance
“…Bonsu and Johnson (2012) reported that there was no significant change in lipid profile in rats given 10g/day inulin in individuals diagnosed with type 2 diabetes. The results of chitosan agreed with that study of Jiang et al (2019) who reported that chitosan consumption can improve lipid profiles of coronary heart disease (CHD) patients. Chitosan and artichoke leaf extracts had significant therapeutic potential in hypercholesterolemia, cardio protective effects and exerts the amelioration of the imbalance of circulated cholesterol and lipoprotein levels in HF diet-fed rats (Küçükgergin et al, 2010 andChiu et al, 2020).…”
Section: Serum Lipid Profile Of Obese Rats Fed On Artichoke Stem By-product (Asp) and Shrimp By-product (Sbp)supporting
confidence: 90%
“…Bonsu and Johnson (2012) reported that there was no significant change in lipid profile in rats given 10g/day inulin in individuals diagnosed with type 2 diabetes. The results of chitosan agreed with that study of Jiang et al (2019) who reported that chitosan consumption can improve lipid profiles of coronary heart disease (CHD) patients. Chitosan and artichoke leaf extracts had significant therapeutic potential in hypercholesterolemia, cardio protective effects and exerts the amelioration of the imbalance of circulated cholesterol and lipoprotein levels in HF diet-fed rats (Küçükgergin et al, 2010 andChiu et al, 2020).…”
Section: Serum Lipid Profile Of Obese Rats Fed On Artichoke Stem By-product (Asp) and Shrimp By-product (Sbp)supporting
confidence: 90%
“…The authors evaluated the effects of chitosan oligo-Circula.ting antioxidant levels were higher in the COS group than in the control group. COS [128] saccharides (COS) on corona.ty heart disease (CHD) consumption increased tbe serum levels of SOD and GSH and reduced the levels of ALT patients.…”
Section: Chito1an Oligosacebarides (Cos)mentioning
confidence: 99%
“…Previous compelling investigations have demonstrated that during the suckling period, Lactobacillus plays a protective role against oxidative damage by upregulating the expression of glutathione reductase and glutathione S-transferase [73,74]. The Lachnospiraceae family participates in the breakdown of carbohydrates and potentially contributes to antioxidative properties [75].…”
Section: The Reshaped Colon Microbiota In Piglets By Smm914mentioning
confidence: 99%